Substituted hepta-1,6-dien-3-ones with green/fruity odours green/galbanum olfactophore model

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 13, 2003, Pages 2931-2946

  Bajgrowicz, Jerzy A ^a   Berg Schultz, Katja ^a,b   Brunner, Gerhard ^a  

^a GIVAUDAN SCHWEIZ AG   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1 CYCLOOCT 1 ENYLPENT 4 EN 1 ONE; 1 [1 (2,2,3 TRIMETHYLCYCLOPENT 3 ENYL)CYCLOPROPYL]PENT 4 EN 1 ONE; 2 (2 METHYLCYCLOHEXYL)HEPTA 1,6 DIEN 3 ONE; 2 (3 METHYLCYCLOHEXYL)HEPTA 1,6 DIEN 3 ONE; 2 CYCLOHEXYLHEPT 1 EN 3 ONE; 2 CYCLOHEXYLHEPTA 1,6 DIEN 3 OL; 2 CYCLOOCTYLHEPTA 1,6 DIEN 3 ONE; 2 CYCLOPENTYLHEPTA 1,6 DIEN 3 OL; 2 METHYL 3 METHYLENEOCT 7 EN 4 ONE; 3 CYCLOHEXYL 2 METHYLOCTA 2,7 DIEN 4 ONE; 6 CYCLOHEXYLNONA 1,6 DIEN 5 ONE; 6 METHYLENEDODEC 1 EN 5 ONE; 8,8 DIMETHYL 6 METHYLENENON 1 EN 5 ONE; CHEMICAL COMPOUND; HEPTA 1,6 DIEN 3 ONE; OIL; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL MODEL; DATA ANALYSIS; FRUIT; GALBANUM; MOLECULAR BIOLOGY; ODOR; SMELLING; STRUCTURE ACTIVITY RELATION;

FERULA GUMMOSA;

EID: 0038547948     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00189-5     Document Type: Article

References (50)

1. For review cf. (a) Rossiter K. Chem. Rev. 96:1996;3201 (b) Fráter G., Bajgrowicz J.A., Kraft P. Tetrahedron. 54:1998;7633 (c) Kraft P., Bajgrowicz J.A., Denis C., Fráter G. Angew. Chem., Int. Ed. 39:2000;2980 (d) Boelens, M. Perfumer Flavorist 2002, 27 (July/August), 34.
2. For review cf. (a) Rossiter K. Chem. Rev. 96:1996;3201 (b) Fráter G., Bajgrowicz J.A., Kraft P. Tetrahedron. 54:1998;7633 (c) Kraft P., Bajgrowicz J.A., Denis C., Fráter G. Angew. Chem., Int. Ed. 39:2000;2980 (d) Boelens, M. Perfumer Flavorist 2002, 27 (July/August), 34.
3. For review cf. (a) Rossiter K. Chem. Rev. 96:1996;3201 (b) Fráter G., Bajgrowicz J.A., Kraft P. Tetrahedron. 54:1998;7633 (c) Kraft P., Bajgrowicz J.A., Denis C., Fráter G. Angew. Chem., Int. Ed. 39:2000;2980 (d) Boelens, M. Perfumer Flavorist 2002, 27 (July/August), 34.
4. Firestein S. Nature. 413:2001;211.
5. Malnic B., Hirono J.T., Sato T., Buck L.B. Cell. 96:1999;713.
6. (a) Zozulya, S.; Echeverri, F.; Nguyen, T. Genome Biol. [online computer file] 2001, 2. URL: http://genomebiology.com/2002/2/6/research/0018.
7. (b) Mombaerts P. Annu. Rev. Genomics Hum. Genet. 2:2001;493 (c) Glusman G., Yanai I., Rubin I., Lancet D. Genome Res. 11:2001;685.
8. Called substantivity by perfumers and fragrance chemists.
9. Gimelbrant A.A., Haley S.L., McClintock T.S. J. Biol. Chem. 1:2000;1.
10. 7-10 aliphatic aldehydes) assay, albeit it is far from being straightforward and its meaningfulness to humans has not been proven: Araneda R.C., Kini A.D., Firestein S. Nat. Neurosci. 3:2000;1248.
11. These approaches, based on slight structural changes of a known lead ('me-too') or combining structural features of different molecules having similar pharmacologoical effects ('mecano') are probably still the most successful approaches in bringing new medicins to the market.
12. Bauer K., Garbe D., Surburg H. Common Fragrance and Flavor Materials. 2001;Wiley-VCH, Weinheim (Ger.). p 196, and references cited therein.
13. (a) Teisseire P., Corbier B., Plattier M. Recherches (Paris). 16:1967;5 (b) Näf F., Decorzant R., Thommen W., Willhalm B., Ohloff G. Helv. Chim. Acta. 58:1975;1016.
14. Berger R.G., Drawert F., Kollmannsberger H., Nitz S. J. Food Sci. 50:1985;1655.
15. Müller D.G., Clayton M.N., Gassmann G., Boland W., Marner F.-J., Schotten T., Jaenicke L. Naturwissenschaften. 72:1985;97. and references therein.
16. (a) Morris A.F., Näf F., Snowden R.L. Perfumer Flavorist. 16:1991;33 (b) Schulte-Elte, K.-H.; Willhalm, B.; Gautschi, F. US Patent 4147672, 1979 (priority 1974, to Firmenich); Chem. Abstr. 1979, 91, 19986.
17. Arctander S. Perfume and Flavor Chemicals (Aroma Chemicals). 1994;Allured, Carol Stream, IL, USA. Vol. 1, No 77.
18. Bauer K., Garbe D., Surburg H. Common Fragrance and Flavor Materials. 2001;Wiley-VCH, Weinheim (Ger.). p 23.
19. Sprecker, M., A. US Patent 4735932, 1988 (priority 1987, to IFF); Chem. Abstr. 1988, 109, 169913.
20. Bauer K., Garbe D., Surburg H. Common Fragrance and Flavor Materials. 2001;Wiley-VCH, Weinheim (Ger.). p 93.
21. Bourdin, B.; Fráter, G.; Bajgrowicz, J. A. Eur. Pat. Appl. 913383, 1999 (priority 1997, to Givaudan); Chem. Abstr. 1999, 130, 338271.
22. Berg-Schultz, K.; Bajgrowicz, J. A. Eur. Pat. Appl. 1063229, 2000 (priority 1999, to Givaudan); Chem. Abstr. 2001, 134, 61263.
23. Goeke, A.; Berg-Schulz, K.; Bajgrowicz, J. A. Eur. Pat. Appl. 1182190, 2002 (priority 2000, to Givaudan); Chem. Abstr. 2002, 136, 199956.
24. (a) Sandermann W., Casten R. Parfuem. Kosmet. 54:1973;335
25. (b) Kraft P. Synthesis. 1999;695.
26. The price criteria and practical aspects are much more constraining and taken into consideration from the very early stages of the fragrance and flavour research than in the pharmaceutical studies.
27. Mukaiyama T., Banno K., Narasaka K. J. Am. Chem. Soc. 96:1974;7503.
28. Neuner-Jehle, N.; Etzweiler, F. In Perfumes: Art, Science and Technology; Müller, P. M.; Lamparsky, D., Eds; Elsevier Applied Science: London, 1991; p 153.
29. Massó T., Portella A., Rus E. Perfumer Flavorist. 15:1990;39.
30. Arctander S. Perfume and Flavor Chemicals (Aroma Chemicals). 1994;Allured, Carol Stream, IL, USA. Vol. 1, No 91.
31. Sprecker, M., A.; Schreiber, W. L.; Belko, R. P. US Patent 4780564, 1988 (priority 1987, to IFF); Chem. Abstr. 1989, 110, 231174.
32. Bajgrowicz J.A., Fráter G. Enantiomer. 5:2000;225.
33. Bajgrowicz J.A., Frank I., Fráter G., Hennig M. Helv. Chim. Acta. 81:1998;1349.
34. Catalyst™ 4.6; Accelrys Inc.: 9685 Scranton Road, San Diego, CA 92121, USA.
35. (a) Greene J., Kahn S., Savoj H., Sprague P., Teig S.J. Chem. Inf. Comput. Sci. 34:1994;1297
36. (b) Smellie A., Teig S.L., Towbin P. J. Comp. Chem. 16:1995;171
37. (c) Smellie A., Kahn S.D., Teig S.L. J. Chem. Inf. Comput. Sci. 35:1995;285. and 295.
38. As it is difficult to find the consensus on the most appropriate ΔE, the values of 5, 10 and 15 kcal/mol were tried. The hypotheses generated using the last two values gave the highest and comparable correlation factor values.
39. Li, H.; Sutter, J.; Hoffmann, R. In Pharmacophore Perception, Development and Use in Drug Design; Guner, O. Ed.; IUL BioTechnology Series; International University Line; La Jolla, 2000; p 173.
40. The correlation factor could have been significantly higher if we had included more inactive molecules, structurally more different from the active ones. This would however not improve the quality of the generated hypotheses.
41. Generated using Moloc software: http://www.moloc.ch .
42. Other possibilities to discriminate between structurally similar active and inactive odorants by delimiting the hypothetical lipophilic part of the binding site consist in placing the Catalyst™ excluded volumes and/or using the shape parameter. They are being tried.
43. Pellet M., Huet F., Conia J.-M. J. Chem. Res. Miniprint. 1982;2546.
44. Igarashi M., Tada M. Synthesis. 1996;465.
45. Garst, M. E.; Syage, E. T. Eur. Pat. Appl. 429287, 1991 (priority 1989, to Allergan); Chem. Abstr. 1991, 115, 183071.
46. Stetter H., Kuhlmann H. Synthesis. 1979;29.
47. Herz W. J. Org. Chem. 20:1955;1062.
48. Hajek M., Malek J. Collect. Czech. Chem. Commun. 45:1980;1940.
49. Marshall J.A., Andersen N.H., Hochstetler A.R. J. Org. Chem. 32:1967;113.
50. Schulte-Elte, K.-H.; Mueller, B.; Pamingle, H. Eur. Pat. Appl. 155591, 1985 (priority 1984, to Firmenich); Chem. Abstr. 1986, 105, 191435.